Abstract:Objectives The objective of this study is to determine the relationship between serum vitamin D level and the risk of developing benign paroxysmal positional vertigo (BPPV) incidence and recurrence in countries in the Northern Hemisphere. Design Systematic review and meta-analysis. Data sources PubMed, Scopus and Web of Science databases were searched for studies published between January 2000 and February 2023. Eligibility criteria for selecting studies Participants located in the Northern Hemisphere aged 18 or over with at least one episode of BPPV, serum 25-hydroxyvitamin D levels measured and reported, no comorbidities or history of vitamin D supplementation. Data extraction and synthesis Data extraction and synthesis were performed by a single reviewer and checked by a second reviewer. Inclusion and exclusion criteria and risk of bias were assessed by two independent reviewers using the Newcastle Ottawa Tool for Cohort studies and Risk of Bias Assessment Tool for Nonrandomised Studies checklist for case–control studies. Meta-analysis was conducted using random effects models. Standard mean difference with a 95% CI was used to measure the relationship between vitamin D level and BPPV. Results The 35 articles identified by the literature search reported data of 9843 individuals. 19 studies (7387 individuals) were included in the BPPV incidence meta-analysis while 7 studies (622 individuals) were included in the BPPV recurrence meta-analysis. Lower serum vitamin D levels were found in BPPV incidence compared with controls, but the relationship between vitamin D levels in recurrent BPPV compared with non-recurrent disease remained uncertain. Conclusion Results of this systematic review and meta-analysis demonstrated a negative correlation between serum vitamin D and BPPV incidence, while any relationship between serum vitamin D and BPPV recurrence remained uncertain. Risk of bias analysis revealed evidence of variable quality. There were insufficient data available to evaluate seasonal relationships between serum vitamin D and BPPV. Given the potential for this as a confounding factor, future research should aim to investigate this further. PROSPERO registration number CRD42021271840.

Update on benign paroxysmal positional vertigo

Vitamin D Supplementation and Recurrence of Benign Paroxysmal Positional Vertigo

Advances in the diagnosis and treatment of benign paroxysmal positional vertigo

Benign Paroxysmal Positional Vertigo Post Osteotome Sinus Floor Elevation - A Case Report

Clinical Practice Update Part I: Diagnosis and Treatment for Benign Paroxysmal Positional Vertigo

Association between serum vitamin D levels and benign paroxysmal positional vertigo: a systematic review and meta-analysis of observational studies

Clinical Practice Update Part II: Considerations for Treatment and Management of Benign Paroxysmal Positional Vertigo

Benign paroxysmal positional vertigo: A practical approach for emergency physicians

Revisiting pathophysiology of benign paroxysmal positional vertigo: a review

Vitamin D supplementation in preventing the recurrence of benign paroxysmal positional vertigo

Do Patients with Benign Paroxysmal Positional Vertigo Have a Higher Prevalence of Osteoporosis? A Systematic Review and Meta-Analysis

Benign paroxysmal positional vertigo: From guidelines to everyday clinical practice

Risk Factors for Residual Dizziness in Patients Successfully Treated for Unilateral Benign Posterior Semicircular Canal Paroxysmal Positional Vertigo.

Knowledge Mapping of Benign Paroxysmal Positional Vertigo from 2002 to 2021: A Bibliometric Analysis

Association between vitamin D deficiency and benign paroxysmal positional vertigo (BPPV) incidence and recurrence: a systematic review and meta-analysis

Less talked variants of benign paroxysmal positional vertigo

Relation between vitamin D deficiency and benign paroxysmal positional vertigo

Addressing the Overlapping Challenges of Benign Paroxysmal Positional Vertigo (BPPV) and Persistent Postural-Perceptual Dizziness (PPPD): Impacts and Integrated Management

Risk Factors for the Recurrence of Benign Paroxysmal Positional Vertigo: A Systematic Review and Meta-Analysis

Residual dizziness after BPPV management: exploring pathophysiology and treatment beyond canalith repositioning maneuvers

Review of the pathology underlying benign paroxysmal positional vertigo